FDA approves first treatment for pediatric patients with lupus - FDA Press Releases

FDA approves Benlysta for treatment of children with systemic lupus erythematosus (SLE), a chronic disease causing inflammation and damage to tissue and organs

from Food and Drug Administration--Press Releases http://bit.ly/2ZCcJgw
via IFTTT